Crossingbridge Advisors’s UnitedHealth UNH Stock Holding History

Crossingbridge Advisors’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,000	Closed	-$1.35M	–	155
2026 Q1	$1.35M	Buy	+5,000	New	+$1.49M	0.24%	78

Other funds holding UNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Crossingbridge Advisors's UNH Position: Q2 2026 in Review

Crossingbridge Advisors sold out of UnitedHealth (UNH) in Q2 2026, closing a stake of 5,000 shares — an estimated $1.35M sold.

Crossingbridge Advisors first reported a position in UNH in Q1 2026 and held it in 1 quarter. The position peaked at $1.35M in Q1 2026. 3,386 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

Crossingbridge Advisors reported no remaining UnitedHealth position as of Q2 2026 after selling out during the quarter.
Crossingbridge Advisors sold 5,000 UnitedHealth shares in Q2 2026, an estimated $1.35M.
Crossingbridge Advisors first reported a position in UnitedHealth in Q1 2026 and held it in 1 quarter.
Crossingbridge Advisors's UnitedHealth position peaked at $1.35M in Q1 2026.
3,386 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Crossingbridge Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.